Goldman Sachs Adjusts Kontron Stake Amid Company's Share Buyback Initiative

Kontron launches a €50M buyback after a weak share price start. Goldman Sachs slightly reduces its voting rights stake, held mostly via financial instruments.

The technology firm Kontron has initiated market support measures following a challenging start to the year. These corporate actions coincide with a notable portfolio adjustment by a major institutional shareholder, unfolding against a backdrop of tempered profit forecasts and costly restructuring efforts.

A Major Shareholder Recalibrates

In a recent regulatory filing, the US investment bank Goldman Sachs reported a change in its voting rights position in Kontron. The bank's total stake now stands at 4.31% of voting rights, a slight decrease from its previous holding of 4.43%. The composition of this interest is noteworthy: direct shareholdings account for only 0.40% of the total, with the substantial majority of the position being held through financial instruments such as securities lending and swaps.

Management Deploys Capital to Support Shares

Responding directly to share price weakness in recent weeks, Kontron's management activated its previously announced share repurchase program at the end of March. In the program's initial two trading days, the company acquired approximately 188,000 of its own shares across various European trading venues. The total consideration for these purchases amounted to roughly €3.5 million, achieved at an average price just above €18.60 per share. The board has authorized a total budget of up to €50 million to buy back a maximum of 2.9 million shares by the end of September 2026.

Earnings Outlook and Restructuring Weigh on Sentiment

Kontron's desire to bolster its market valuation is understandable given its year-to-date performance. Since the beginning of January, the share price has declined by 17.75%, closing at €19.28 in the latest session. This downward pressure was recently exacerbated by a disappointing financial forecast. The company's targeted EBITDA of €225 million for 2026 fell significantly short of the average analyst estimate of €246 million. Furthermore, the planned restructuring of its loss-making clean-tech business, which entails one-time costs of approximately €25 million, is placing additional strain on the current financial statements.

Despite near-term headwinds, the leadership team expresses confidence in its long-term strategic direction. Management is targeting nearly a doubling of EBITDA to €420 million by 2030. This optimism is supported by a growing order backlog, which has now reached €2.5 billion. Analysts at Jefferies have maintained their "buy" recommendation on the stock with a price target of €27, indicating that experts anticipate an operational recovery for the company in the medium term, even amidst its current transitional phase.